MarketCap
Assembly Biosciences ASMB
€ 19.00
-0.93%
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBALSPB |
Anteile |
11.2 M |
Marktkapitalisierung |
$ 239 M |
EBITDA (LTM) |
$ -12 M |
P/E (LTM) |
-66.545455 |
P/S (LTM) |
5.675009 |
EPS (LTM) |
-0.55 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Pliant Therapeutics
PLRX
|
$ 0.78 | -2.19 % | $ 47.9 M | Nasdaq Global Select Market | USA |
 |
Pharming Group N.V.
PHAR
|
$ 13.02 | -1.06 % | $ 8.97 B | Nasdaq Global Select Market |  Niderland |
 |
Catabasis Pharmaceuticals, Inc.
CATB
|
- | -6.97 % | $ 657 M | Nasdaq Global Market | USA |
 |
Capricor Therapeutics
CAPR
|
$ 8.91 | -9.54 % | $ 414 M | Nasdaq Capital Market | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 29.06 | -1.09 % | $ 1.36 B | Nasdaq Global Select Market | USA |
 |
China Biologic Products Holdings, Inc.
CBPO
|
- | 1.68 % | $ 4.65 B | Nasdaq Global Select Market |  China |
 |
Aquestive Therapeutics
AQST
|
$ 3.52 | -0.56 % | $ 376 M | Nasdaq Global Market | USA |
 |
Jaguar Health
JAGX
|
$ 0.44 | -0.21 % | $ 1.03 M | Nasdaq Capital Market | USA |
 |
Arvinas
ARVN
|
$ 6.9 | 2.07 % | $ 489 M | Nasdaq Global Select Market,SPB | USA |
 |
Cerus Corporation
CERS
|
$ 1.95 | -6.04 % | $ 372 M | Nasdaq Global Market | USA |
 |
Beam Therapeutics
BEAM
|
$ 25.16 | -6.88 % | $ 2.49 B | Nasdaq Global Select Market | USA |
 |
Pulmatrix
PULM
|
$ 1.39 | 2.58 % | $ 5.08 B | Nasdaq Global Select Market | USA |
 |
Fortress Biotech
FBIO
|
$ 1.9 | -4.52 % | $ 53 M | Nasdaq Capital Market | USA |
 |
Inhibrx
INBX
|
$ 90.63 | -1.21 % | $ 4.27 B | Nasdaq Global Select Market | USA |
 |
Entera Bio Ltd.
ENTX
|
$ 3.24 | -0.31 % | $ 150 M | Nasdaq Capital Market |  Israel |
 |
Flexion Therapeutics, Inc.
FLXN
|
- | - | $ 459 M | Nasdaq Global Market | USA |
 |
Legend Biotech Corporation
LEGN
|
$ 20.25 | -16.63 % | $ 7.46 B | Nasdaq Global Select Market | USA |
 |
CytomX Therapeutics
CTMX
|
$ 2.0 | 0.76 % | $ 276 M | Nasdaq Global Select Market | USA |
 |
Krystal Biotech
KRYS
|
$ 306.47 | 1.13 % | $ 8.87 B | Nasdaq Global Market,SPB | USA |
 |
Kura Oncology
KURA
|
$ 7.56 | -0.13 % | $ 663 M | Nasdaq Global Select Market | USA |
 |
Inhibikase Therapeutics
IKT
|
$ 1.58 | -6.25 % | $ 155 M | Nasdaq Capital Market | USA |
 |
Heron Therapeutics
HRTX
|
$ 0.38 | 1.38 % | $ 63.3 M | Nasdaq Global Select Market,SPB | USA |
 |
Inovio Pharmaceuticals
INO
|
$ 1.47 | -2.98 % | $ 68.9 M | Nasdaq Global Select Market | USA |
 |
Corvus Pharmaceuticals
CRVS
|
$ 11.36 | 0.09 % | $ 897 M | Nasdaq Global Market | USA |
 |
Aytu BioScience
AYTU
|
$ 1.83 | 2.23 % | $ 22.5 M | Nasdaq Capital Market | USA |
 |
Heat Biologics, Inc.
HTBX
|
- | -5.76 % | $ 99.8 M | Nasdaq Capital Market | USA |
 |
Innoviva
INVA
|
$ 19.08 | 0.39 % | $ 1.29 B | Nasdaq Global Select Market | USA |
 |
BioCardia
BCDA
|
$ 0.95 | 2.66 % | $ 6.33 M | Nasdaq Global Select Market | USA |
 |
Kindred Biosciences, Inc.
KIN
|
- | 0.11 % | $ 419 M | Nasdaq Global Select Market | USA |
 |
Alterity Therapeutics Limited
ATHE
|
$ 2.3 | -5.35 % | $ 14.7 B | Nasdaq Capital Market |  Australia |
 |
Shineco, Inc.
TYHT
|
- | -3.90 % | $ 97.2 M | Nasdaq Global Select Market | China |
 |
Millendo Therapeutics, Inc.
MLND
|
- | -5.36 % | $ 20.2 M | Nasdaq Global Select Market | USA |
 |
Certara
CERT
|
$ 12.21 | -0.08 % | $ 1.96 B | Nasdaq Global Select Market | USA |
 |
Dyadic International
DYAI
|
$ 0.39 | 1.16 % | $ 14.1 M | Nasdaq Capital Market | USA |
 |
Intec Pharma Ltd
NTEC
|
- | -12.45 % | $ 17.7 M | Nasdaq Capital Market | Israel |
 |
Anika Therapeutics
ANIK
|
$ 13.42 | -7.89 % | $ 192 M | Nasdaq Global Select Market,SPB | USA |
 |
Aprea Therapeutics
APRE
|
$ 0.45 | -9.44 % | $ 2.94 M | Nasdaq Global Select Market,SPB | USA |
 |
Galectin Therapeutics
GALT
|
$ 3.4 | -1.73 % | $ 217 M | Nasdaq Global Select Market | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
$ 73.22 | -2.41 % | $ 7.6 B | Nasdaq Capital Market,SPB | USA |
 |
Progenity, Inc.
PROG
|
- | -3.47 % | $ 164 M | Nasdaq Global Select Market | USA |
 |
Genprex
GNPX
|
$ 2.1 | 1.94 % | $ 1.96 M | Nasdaq Capital Market | USA |
 |
Strongbridge Biopharma plc
SBBP
|
- | 1.52 % | $ 136 M | Nasdaq Global Select Market | USA |
 |
Innate Pharma S.A.
IPHA
|
$ 1.54 | 1.98 % | $ 138 M | Nasdaq Global Select Market |  France |
 |
Seneca Biopharma, Inc.
SNCA
|
- | -1.19 % | $ 28.7 M | Nasdaq Capital Market | USA |
 |
BioMarin Pharmaceutical
BMRN
|
$ 57.1 | -0.14 % | $ 11 B | Nasdaq Global Select Market,SPB | USA |
 |
Matinas BioPharma Holdings
MTNB
|
$ 1.19 | -4.03 % | $ 6.51 M | NYSE American | USA |
 |
Enanta Pharmaceuticals
ENTA
|
$ 11.24 | -2.01 % | $ 240 K | Nasdaq Global Select Market,SPB | USA |
 |
SIGA Technologies
SIGA
|
$ 3.14 | -3.83 % | $ 225 M | Nasdaq Global Select Market | USA |
 |
Milestone Pharmaceuticals
MIST
|
$ 0.68 | -7.49 % | $ 72.2 M | Nasdaq Global Select Market |  Canada |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 94.9 | -3.91 % | $ 7.04 B | Nasdaq Global Select Market | USA |